SCHEMBL8745476

SCHEMBL8745476

COC(=O)[C@](C)(N)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.52
TAAR1 Q96RJ0 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HIF1A Q16665 1/20 0.52
BLM P54132 2/20 0.50
MMP8 P22894 3/20 0.49
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPRA P18433 1/20 0.49
PTPRB P23467 1/20 0.49
KCNN4 O15554 1/20 0.47
RECQL P46063 3/20 0.46
CYP3A4 P08684 3/20 0.46
CYP1A2 P05177 2/20 0.46
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
LMNA P02545 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632109 1.00 SLC6A2 (0.52) SLC6A2TAAR1SMN1; SMN2HIF1ABLM
SCHEMBL5180745 1.00 SLC6A2 (0.52) SLC6A2TAAR1SMN1; SMN2HIF1ABLM
Hydrochloric Acid SCHEMBL2210722 0.98 SMN1; SMN2 (0.50) SLC6A2TAAR1SMN1; SMN2HIF1ABLM
Hydrochloric Acid SCHEMBL1311456 0.98 SMN1; SMN2 (0.50) SLC6A2TAAR1SMN1; SMN2HIF1ABLM
Hydrochloric Acid SCHEMBL2210717 0.98 SMN1; SMN2 (0.50) SLC6A2TAAR1SMN1; SMN2HIF1ABLM
Methyl Alcohol SCHEMBL11329639 0.97 SMN1; SMN2 (0.49) SLC6A2TAAR1SMN1; SMN2HIF1ABLM
SCHEMBL1811750 0.91 FDPS (0.46) SLC6A2TAAR1SMN1; SMN2HIF1ABLM
SCHEMBL540243 0.84 BLM (0.67) BLMPTPN2PTPN1PTPRAPTPRB
SCHEMBL503525 0.84 BLM (0.67) BLMPTPN2PTPN1PTPRAPTPRB
SCHEMBL503526 0.84 BLM (0.67) BLMPTPN2PTPN1PTPRAPTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021030469-A1 THERAPEUTIC MITOCHONDRIAL PEPTIDES COHBAR, INC. (US) 2021-02-18 WO disclosed
WO-2021030749-A1 THERAPEUTIC PEPTIDES COHBAR, INC. (US) 2021-02-18 WO disclosed
EP-3668886-A2 TAU AGGREGATION PEPTIDE INHIBITORS Adrx, Inc. (US) 2020-06-24 EP disclosed
WO-2019036725-A2 TAU AGGREGATION PEPTIDE INHIBITORS ADRX, INC. (US) 2019-02-21 WO disclosed
WO-2018156892-A1 PEPTIDE INHIBITORS OF TRANSCRIPTION FACTOR AGGREGATION ADRX, INC. (US) 2018-08-30 WO disclosed
EP-3303367-A1 STABILIZED MINIMAL COILED-COIL MIMETICS New York University (US) 2018-04-11 EP disclosed
WO-2016201007-A1 STABILIZED MINIMAL COILED-COIL MIMETICS NEW YORK UNIVERSITY (US) 2016-12-15 WO disclosed
CN-1211232-A Benzamidine derivatives substituted with amino acid and hydroxy acid derivatives and their use as anticoagulants BERLEX LAB (US) 1999-03-17 CN disclosed
US-5610145-A CARBAMATE STEREOISOMERS WARNER-LAMBERT COMPANY (US) 1997-03-11 US disclosed
EP-0755404-A1 TACHYKININ ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-01-29 EP disclosed
WO-1995028418-A2 TACHYKININ ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1995-10-26 WO disclosed